Literature DB >> 10563824

Probing the folding and unfolding of wild-type and mutant forms of bacteriorhodopsin in micellar solutions: evaluation of reversible unfolding conditions.

G Q Chen1, E Gouaux.   

Abstract

Wild-type and mutant forms of bacteriorhodopsin (sbR) from Halobacterium salinarium, produced by Escherichia coli overexpression of a synthetic gene, were reversibly unfolded in 1, 2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 3-[(3-cholamidopropyl)dimethylamino]-2-hydroxyl-1-propane (CHAPSO), and sodium dodecyl sulfate (SDS) mixed micelles. To study the effect on protein stability by substitutions on the hydrophobic surface with polar residues, the unfolding behavior of a G113Q, G116Q mutant [sbR(Q2)] was compared to the wild-type sbR [sbR(WT)]. sbR(Q2) was more sensitive to SDS-induced unfolding than sbR(WT) under equilibrium conditions, and kinetic experiments showed that sbR(Q2) was more sensitive to acid-induced denaturation and thermal unfolding than sbR(WT). Since the mutations in sbR(Q2) were on the detergent-embedded hydrophobic surface of sbR, protein destabilization by these mutations supports the concept that the membrane-embedded segments are important for the stability of sbR. Our experiments provide the basis for studying the thermodynamic stability of sbR by evaluating reversible folding and unfolding conditions in DMPC/CHAPSO/SDS mixed micelles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563824     DOI: 10.1021/bi9909039

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  How do helix-helix interactions help determine the folds of membrane proteins? Perspectives from the study of homo-oligomeric helical bundles.

Authors:  William F DeGrado; Holly Gratkowski; James D Lear
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

2.  Cooperativity and specificity of association of a designed transmembrane peptide.

Authors:  Holly Gratkowski; Qing-Hong Dai; A Joshua Wand; William F DeGrado; James D Lear
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

3.  Membrane proteins: a new method enters the fold.

Authors:  James U Bowie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

4.  Revisiting the folding kinetics of bacteriorhodopsin.

Authors:  Jonathan P Schlebach; Zheng Cao; James U Bowie; Chiwook Park
Journal:  Protein Sci       Date:  2011-12-05       Impact factor: 6.725

5.  Transmembrane helix-helix association: relative stabilities at low pH.

Authors:  Neelima Valluru; Frances Silva; Manmath Dhage; Gustavo Rodriguez; Srinivas R Alloor; Robert Renthal
Journal:  Biochemistry       Date:  2006-04-11       Impact factor: 3.162

6.  Combined kinetic and thermodynamic analysis of alpha-helical membrane protein unfolding.

Authors:  Paul Curnow; Paula J Booth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

7.  Free energy of membrane protein unfolding derived from single-molecule force measurements.

Authors:  Johannes Preiner; Harald Janovjak; Christian Rankl; Helene Knaus; David A Cisneros; Alexej Kedrov; Ferry Kienberger; Daniel J Muller; Peter Hinterdorfer
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

8.  Measuring membrane protein stability under native conditions.

Authors:  Yu-Chu Chang; James U Bowie
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

9.  Overcoming hysteresis to attain reversible equilibrium folding for outer membrane phospholipase A in phospholipid bilayers.

Authors:  C Preston Moon; Sarah Kwon; Karen G Fleming
Journal:  J Mol Biol       Date:  2011-08-24       Impact factor: 5.469

10.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.